Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Peter Joseph

Dentist, Periodontics Owings Mills, MD Doctor of Dentistry

NPI 1366739278 CMS profile 197609

66 Painters Mill Rd, Suite 100, Owings Mills, MD 21117

Open in the dashboard

General payments

$9,377

128 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Peter Joseph of Owings Mills, MD is reported in the CMS Open Payments database as having received $9,377 across 128 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Dentist, Periodontics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $179 13
2024 General $1,009 23
2023 General $1,659 26
2022 General $3,898 27
2021 General $517 10
2020 General $331 7
2019 General $1,784 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Peter Joseph
  • Dentist, Periodontics median
  • Middle half of Dentist, Periodontics
  • National median

In program year 2025, general payments to Peter Joseph were reported at $179. Among 2,732 Dentist, Periodontics profiles paid that year, the median was $112 and the middle half received between $42 and $307.

Show as a table
Year Peter Joseph Dentist, Periodontics median Middle half National median
2019 $1,784 $129 $42–$367 $163
2020 $331 $90 $35–$265 $114
2021 $517 $125 $42–$411 $132
2022 $3,898 $123 $43–$364 $149
2023 $1,659 $125 $45–$358 $160
2024 $1,009 $119 $42–$350 $164
2025 $179 $112 $42–$307 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. BioHorizons Implant Systems Inc. $3,571 19 payments
  2. Zimvie Inc. $3,083 66 payments
  3. Zimmer Biomet Holdings, Inc. $2,393 35 payments
  4. Align Technology, Inc. $115 2 payments
  5. Salvin Dental Specialties, Inc. $108 1 payment
  6. Zest Holdings, LLC $62 3 payments
  7. Dentsply Sirona Inc $26 1 payment
  8. OraPharma, a division of Bausch Health US, LLC $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,729 118 payments
  2. Travel and Lodging $4,348 9 payments
  3. Education $300 1 payment
Products named General payments · program years 2019–2025
  1. BIOHORIZONS Implant Dentistry $3,555 18 payments
  2. BIOHORIZONS Implant Dentistry $3,555 18 payments
  3. BIOHORIZONS Implant Dentistry $3,555 18 payments
  4. BIOHORIZONS Implant Dentistry $3,555 18 payments
  5. BIOHORIZONS Implant Dentistry $3,555 18 payments
  6. Diem2 $1,110 6 payments
  7. Tapered Screw-Vent $1,003 10 payments
  8. TSX Implants $781 23 payments
  9. Tapered Screw $781 14 payments
  10. 3DIEMME RealGUIDE $496 9 payments
  11. Other $1,483 43 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

655

Median for Dentist: 47

Drug cost

$3,207

Median for Dentist: $159

Branded share of claims

2%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 256 $1,055
Ibuprofen Generic 175 $455
Metronidazole Generic 30 $418
Fluocinonide Generic 11 $339
Azithromycin Generic 54 $263
Prevident Fluoride (Sodium) Brand 13 $241
Clindamycin Hcl Generic 26 $181
Fluconazole Generic 14 $135
Tramadol Hcl Generic 54 $87
Lorazepam Generic 22 $33

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ARESTIN
  • OraPharma, a division of Bausch Health US, LLC $10
$10 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

128 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Periodontics in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record